Rudolph E. Tanzi
Scientific Founder
Acta Pharmaceuticals
Alzheimer's therapies for early intervention and prevention, led by gamma-secretase modulator research
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Acta Pharmaceuticals, Inc. is a Boston biotech translating Alzheimer's research pioneered by scientific founder Dr. Rudolph E. Tanzi into clinical candidates for early intervention and prevention. Its lead program, GSM-779690T, is an oral gamma-secretase modulator in a Phase 1 healthy-volunteer study. In October 2026 the company announced closing $24 million in seed financing to advance the pipeline, alongside a combination-therapies discovery effort based on Alzheimer's-in-a-Dish models.
- Website
- actapharmaceuticals.com
- Stage
- seed
- Location
- Boston, MA, USA
- Added via
- web
- Ownership
- unclaimed
Where to go
For people
- Homepageactapharmaceuticals.com
For agents
Nothing listed yet.
Products
- GSM-779690T — Oral gamma-secretase modulator in Phase 1 for early Alzheimer's intervention · Other
Social profiles
Links
Founders
George Alex
Co-founder and CEO